Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oligofer
- Development stage
- Unknown
- Lead developer
- Italfarmaco
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Oligofer is an oral iron supplement containing ferric proteinsuccinylate, a trivalent iron (Fe3+) complex. Developed and marketed by ITF İlaç Sanayi ve Ticaret (a subsidiary of Italfarmaco), it is indicated for the treatment of iron deficiency and iron deficiency anemia. The formulation is an oral solution designed to protect the iron complex from gastric acid, allowing for release in the alkaline environment of the small intestine, which improves tolerability and reduces gastrointestinal side effects compared to traditional iron salts.
- Brand names
- Oligofer
- Other names
- ferric proteinsuccinylateiron proteinsuccinylate
Beyond the preview
Go deeper on Oligofer.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oligofer.